儿童药物性肝损伤34例分析*

doi:10.3969/j.issn.1672-5069.2016.05.026

Abstract

Du Shuixian, Lu Linlin, Miao Yingxia, et al.. Features of children with drug-induced liver injury:An analysis of 34 cases[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(5): 607-609.

[1] Amin MD,Harpavat S,Leung DH. Drug-induced liver injury in children. Curr Opin Pediatr,2015,27（5）:625-633.
[2] Yun Z,Li YG,Wu JB,et al. Causes,features,and outcomes of drug-induced liver injury in 69 children from China. Gut Liver,2015,9（4）:525-533.
[3] Danan G,Benichou E. Causality assessment of adverse reactions to drugs-I. A novel method based on the conclusions of international consensus meetings:application to drug-induced liver injuries. J Clin Epidemiol,1993,46（11）:1323-1330.
[4] Standardization of definitions and criteria of causality assessment of adverse drug reactions. Drug-induced liver disorders:report of an international consensus meeting. Int J Clin Pharmacol Ther Toxic,1990,28:317-322.
[5] 中华医学会肝病学分会药物性肝病学组. 药物性肝损伤诊治指南. 肝脏,2015,10:750-766.
[6] Pineiro-Carrero VM,Pineiro EO. Liver. Pediatrics,2004,113:1097-1106.
[7] Andrade RJ,Lucena MI,Fernández MC,et al. Drug-induced liver injury:an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology,2005,129:512-521.
[8] 王淑珍,高珊,刘燕敏,等. 31例小儿药物性肝损伤的临床特点分析. 中华肝脏病杂志,2012,20（3）:193-195.
[9] Kleiner DE,Chalasani NP,Lee WM,et al. Hepatic histological findings in suspected drug-induced liver injury:systematic evaluation and clinical associations. Hepatology,2014,59:661-670.
[10] Molleston JP,Fontana RJ,Lopez MJ,et al. Characteristics of idiosyncratic drug-induced liver injury in children:results from the DILIN prospective study. J Pediatr Gastroenterol Nutr,2011,53:182-189.
[11] Devarbhavi H,Karanth D,Prasanna KS,et al. Drug-induced liver injury with hypersensitivity features has a better outcome:a single-center experience of 39 children and adolescents. Hepatology,2011,54:1344-1350.
[12] Hunt CM. Mitochondrial and immunoallergic injury increase risk of positive drug rechallenge after drug-induced liver injury:a systematic review. Hepatology,2010,52:2216-2222.
[13] Schoepfer AM,Engel A,Fattinger K,et al. Herbal does not mean innocuous:ten cases of severe hepatotoxicity associated with dietary supplements from herbal products. J Hepatol,2007,47:521-526.
[14] Li FY,Li J,Xiao XH. Research status of herbal drug-induced liver injury. Chin J Tradit Chin Med Pharmacol,2009,24:265-269.
[15] Bunchorntavakul C,Reddy KR. Review article:herbal and dietary supplement hepatotoxicity. Aliment Pharmacol Ther,2013,37:3-17.
[16] Skoulidis F,Alexander GJ,Davies SE. Mahuang associated acute liver failure requiring liver transplantation. Eur J Gastroenterol Hepatol,2005,17:581-584.
[17] Liu HC,Liu HY. The liver damage of herbs and the other botanical herbs. Chin Hepatol,2001,6:52-53.
[18] Nam SW,Baek JT,Lee DS,et al. A case of acute cholestatic hepatitis associated with the seeds of Psoralea corylifolia （Boh-Gol-Zhee）. Clin Toxicol （Phila）,2005,43:589-591.
[19] Dong Y,Wang J,Yang Q,et al. Current status on the interaction of cytochrome P450 and metabolism of Chinese materia medica. Chin J Inf Tradit Chin Med,2011,18:100-103.
[20] Guerra MC,Speroni E,Broccoli M,et al. Comparison between Chinese medical herb Pueraria lobata crude extract and its main isoflavone puerarin antioxidant properties and effects on rat liver CYP-catalysed drug metabolism. Life Sci,2000,67:2997-3006.
[21] Bjornsson HK,Olafsson S,Bergmann OM,et al. A prospective study on the causes of notably raised alanine aminotransferase （ALT）. Scand J Gastroenterol,2016,51（5）:594-600.
[22] Bjornsson E. Drug-induced liver injury:Hy , s rule revisited. Clin Pharmacol Ther,2006,79（6）:521-528.
[23] Verma S,Kaplowitz N. Diagnosis,management and prevention of drug-induced liver injury. Gut,2009,58:1555-1564.

Features of children with drug-induced liver injury:An analysis of 34 cases

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Zhang Xuan, Tang Xiaoyun, Tang Chunyin, et al. Effect of Chinese herbal medicine on intestinal microflora in mice with D-galactosamine/LPS-induced acute liver failure [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 478-481.
[2]	Zhang Lanhua, Shao Qin, Xia Zhenjuan. Changes of serum 25-(OH) D3 and IL-17 levels are associated with progress of nonalcoholic fatty liver disease in obese children [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 522-525.
[3]	Wang Baodan, Li Meng, Gao Yu. Predictive factors of response to interferon-α antiviral therapy in children with chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 345-348.
[4]	Liu Liwei, Zhao Xinyan. Clinicopathological features of drug-induced liver injury [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 160-163.
[5]	Huang Chunyang, Shan Jing, Liao Huiyu, Huang Yunli, Han Ying, Zhang Xiaodan, Du Xiaofei, Ren Meixin, Bian Xinqu, Liu Yanmin. Clinical and laboratory characteristics of patients with drug-induced liver injury receiving glucocorticoid therapy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 208-211.
[6]	Wu Xiuxin, Zhang Huiyong, Zhang Kai. Changes of plasma microRNA-4284 in patients with anti-tuberculosis drug-induced hepatotoxicity [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 212-215.
[7]	Sun Wenjing, Chen Dongfeng.. Literature analysis about RUCAM scale and Maria scale in diagnosis of Chinese patients with drug-induced liver injury [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 881-884.
[8]	Cao Haixia, Fan Jiangao. Brief introduction of ESPGHAN recommendation for the diagnosis and treatment of children with Wilson's disease [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(4): 502-504.
[9]	Zhang Caiyuan, Li Jinning, Liu Huanhuan, et al. Application of PRETEXT staging system in evaluating treatment response of children with hepatoblastoma [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(4): 505-508.
[10]	Tong Xin, Fan Hua. Efficacy of bicyclic alcohol on liver function in gastric cancer patients with chemotherapy-induced liver injury [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(4): 625-626.
[11]	Liu Cong, Wang Tingting, Zuo Lili, et al. Analysis of patients with drug-induced liver injury in recent 3 years [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(4): 639-640.
[12]	Lei Yanming, Danzeng Luobu, Dunzhu Ciren. CT features of children with hepatoblastoma [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(4): 649-650.
[13]	Liu Liangyi, Su Dongyuan. Comparison of clinical and liver pathological features of patients with drug-induced liver injury and autoimmune hepatitis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(3): 463-464.
[14]	Zeng Jing，Fan Jiangao. Brief introduction of NASPGHAN clinical practice guideline for the diagnosis and treatment of nonalcoholic fatty liver?disease in children [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(5): 656-657.
[15]	Wei Lujia, Li Qingxiang, Ji Qingwei.. Clinical features of amiodarone-induced acute liver injury [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(4): 424-426.